文献速递药物不良反应与药物警戒

VigiBase数据库更新:全球药品与疫苗不良事件报告模式与趋势概要

VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines.
PubMed 文献 · Drug Saf · 2026-01-30

VigiBase是世界卫生组织(WHO)全球药品与疫苗不良事件报告数据库,收集WHO国际药物监测计划成员国的疑似不良事件信息。本文介绍数据库基础设施更新,并总结全球报告特征的模式与趋势以及数据的优势与局限性。

要点

  • 报告来自160多个国家,采用WHODrug和MedDRA®标准术语编码。
  • 数据库自1968年建立,促进不良事件报告数据的国际统一化,服务于药物警戒信号管理。

主要发现

  • 约80%的报告涉及药品,约20%涉及疫苗。
  • 报告来自160多个国家,采用WHODrug和MedDRA®标准术语编码。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

VigiBase, the WHO global database of adverse event reports for medicines and vaccines, receives information on suspected adverse effects of medicinal products from countries, regions and territories that are members of the WHO Programme for International Drug Monitoring. The database serves as a global resource for pharmacovigilance signal management and scientific development. Its initial establishment through the programme in 1968 has also contributed to the international harmonisation of adverse event report data. As of 31 December 2024, the database includes over 40 million individual case reports coded in standard terminologies (WHODrug and MedDRA®). These reports, of which ~ 80% relate to medicines and ~ 20% to vaccines, come from over 160 countries. This profile paper aims to provide an update on the database infrastructure including data capture, management and analysis tools. It also presents a summary of global patterns and trends of key report characteristics, as well as strengths and limitations of the data to offer context to users and the global pharmacovigilance community.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Brand JS, Gauffin O, Sartori D, et al. VigiBase: Resource Profile Update with a Summary of Global Patterns and Trends in Adverse Event Reports for Medicines and Vaccines. Drug Saf. 2026. PMID: 41618069. doi:10.1007/s40264-025-01642-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。